(TSX-V:CLIP),(OTC US:CLPMF),(Other OTC:CLPMF), ATLANTA, Dec. 08, 2025 (GLOBE NEWSWIRE) — Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), operator of North America's only multi-bank cash deposit system for businesses with over 8,000 deposit accepting locations, is pleased to announce an expanded portfolio partnership with Centennial, a leading retail and mixed-use real […]

(NASDAQ:BCAL), San Diego, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — California Bancorp (the “Company”) (Nasdaq: BCAL), the holding company for California Bank of Commerce, N.A. (the “Bank”), announces that its Board of Directors has approved the Company's first quarterly cash dividend. This strategic decision reflects the Company's strong financial performance and commitment to creating shareholder

(NASDAQ:SABS),(NASDAQ:SABSW), MIAMI, Dec. 08, 2025 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the Company will give several oral presentations at the 2nd Asian Conference on Innovative Therapies for Diabetes Management (ATTD-Asia) being held

– NON-MTS & BILATERAL MTLE: First data reported from non-MTS and bilateral MTLE subjects demonstrate robust seizure reduction – LOW DOSE COHORT: 89% median reduction in disabling seizures for unilateral subjects with MTS at the primary efficacy evaluation period of 7-12 months post administration (n=9) – HIGH DOSE COHORT: 78% median reduction in disabling seizures

DENVER, Dec. 08, 2025 (GLOBE NEWSWIRE) — With talent acquisition teams getting ready for the new year, Employ Inc., a leading provider of people-first, intelligent hiring solutions across JazzHR, Lever, and Jobvite, today shared findings from its 2025 Recruiter Nation Report – Recruiting Realities: What's Shaping TA Today that show the vast majority (76 percent)

(NASDAQ:FDMT), EMERYVILLE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference.

(Other OTC:GAMI),(OTC US:GAMI),(NYSE:KDVD), GREENWICH, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”) today announced the launch of the Keeley Dividend ETF (“KDVD”) on the NYSE. KDVD is an actively managed ETF that seeks to generate current income and capital appreciation by investing in dividend-paying small- and mid-cap companies. The fund is managed

(NYSE MKT:GRO),(Bovespa:GROP31.SA), Signed Contracts to Sell ~91% of Production, Strengthened Leadership Team, Advanced Site Preparation and Community Partnerships 2026 Focus on Construction Financing, Completing Advanced Engineering, Indigenous Impact Benefit Agreement, and Strategic Partnerships CEO Matt Simpson to outline company progress and discuss market dynamics in upcoming investor webinar on December 9, 2025, at 1:00 PM

(NASDAQ:NWTG), AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) — via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.

Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) — GeoCue announces the premiere of a new three-part edition of its award-winning reality series Down to Earth: Mapped Safe for 911. The latest episodes follow Fenstermaker, NEI, and the Lafayette Parish School System as they work with Lafayette Parish 911 to map every public and private school,